Innovations & Research
The people and places racing to revolutionize cancer care.
The landscape of lung cancer is changing, but there’s still work to be done. Dr. Michael Liptay is one health care professional spearheading the push for preventive action.
The COVID-19 pandemic is shaping the way we approach cancer screenings. Low-cost, less invasive and more convenient testing options are on the horizon.
Though more common in women, breast cancer is devastating another demographic—men.
People aren’t perfect, and artificial intelligence may be the answer to bridging the gaps in pathology left by human error.
For Shepherd Therapeutics founder David Hysong, “rare isn’t rare” is more than just a slogan when it comes to oncology. It is a battle cry rooted in his personal fight against cancer.
A common medication used to treat acid reflux was taken off the market two years ago, but its health hazards—including cancer risk—are ongoing.
Women researchers are important to cancer science, yet the oncology field often fails at properly recognizing it. Organizations like Women Who Conquer Cancer and ResearcHERS are working to shatter the glass ceiling.
While pushing for the option of women taking matters into their own hands when it comes to birth control, Saundra Pelletier was doing the same with her breast cancer diagnosis.
The research behind the mRNA-based vaccines used to minimize severe COVID-19 cases has another potential use—fighting cancer.